Condition
3-hydroxy-3-methylglutaryl-CoA Lyase Deficiency
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
6 treatments under study, led by Obtaining Dry Blood Spots From Highrisk Childrens Aged 8 18 Years
Related Conditions
Often studied with 20 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Unknown1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Obtaining Dry Blood Spots From Highrisk Childrens Aged 8 18 Years1
- Obtaining Dry Blood Spots From Healthy Newborns Aged 17 Days1
- Obtaining Dry Blood Spots From Highrisk Newborns Aged 17 Days1
- Obtaining Dry Blood Spots From Healthy Children Aged 8 Days 7 Years1
- Obtaining Dry Blood Spots From Highrisk Childrens Aged 8 Days 7 Years1
Active Sponsors
- West Kazakhstan Medical University1
Top Investigators
West Kazakhstan Medical University
West Kazakhstan Medical University
West Kazakhstan Medical University
Related Conditions
- Longchain 3hydroxyacylcoa Dehydrogenase Deficiency1
- Mediumchain Acylcoa Dehydrogenase Deficiency1
- Betaketothiolase Deficiency1
- Very Longchain Acylcoa Dehydrogenase Deficiency1
- Isovaleric Acidemia1